T80.A10A Non-ABO incompatibility with acute hemolytic transfusion reaction, initial encounter

Name of the Condition

• Non-ABO incompatibility with acute hemolytic transfusion reaction, initial encounter.

Summary

This condition describes an acute hemolytic transfusion reaction resulting from non-ABO blood group incompatibility during the initial encounter. It occurs when the recipient’s immune system reacts to non-ABO antigens in transfused blood or blood products, leading to rapid hemolysis and associated clinical manifestations. The "initial encounter" designation indicates this is the first time the patient is being seen for this specific reaction.

Causes

Acute hemolytic reactions due to non-ABO incompatibility are triggered by immune responses to minor blood group antigens (e.g., Rh, Kell, Duffy, or Kidd systems) or antibodies against platelet or plasma proteins. These reactions may result from prior sensitization through pregnancy, previous transfusions, or organ transplants, where the recipient has developed antibodies against these antigens.

Risk Factors

• Prior exposure to incompatible blood products
• History of multiple transfusions or pregnancies
• Underlying immune-mediated conditions
• Use of blood products with non-ABO antigen mismatches
• Lack of pre-transfusion antibody screening in high-risk patients

Symptoms

• Fever, chills, or rigors
• Skin reactions (rash, urticaria, or flushing)
• Respiratory distress (wheezing, shortness of breath)
• Hypotension or tachycardia
• Hemolysis (evidenced by dark urine or jaundice)
• Renal impairment or oliguria
• Pain at the infusion site

Diagnosis

Diagnosis involves correlating clinical symptoms with transfusion history, performing direct antiglobulin testing, antibody screening, or crossmatching. Documentation of the reaction’s timing, severity, and laboratory findings is critical for confirmation.

Treatment Options

Treatment focuses on discontinuing the transfusion, maintaining hemodynamic stability, and managing hemolysis. Interventions may include fluid resuscitation, vasopressors, diuretics, or renal support. Additional measures include monitoring for complications and providing supportive care.

Prognosis and Follow-Up

Prognosis depends on the reaction’s severity and promptness of treatment. Most patients recover with appropriate management, but severe cases may lead to renal failure or other complications. Follow-up includes monitoring renal function, hemoglobin levels, and antibody status to prevent future reactions.

Complications

• Acute kidney injury or renal failure
• Disseminated intravascular coagulation (DIC)
• Shock or cardiovascular collapse
• Multi-organ dysfunction

Lifestyle & Prevention

Prevention involves thorough pre-transfusion antibody screening, crossmatching, and using leukoreduced or antigen-matched blood products. Patients with a history of sensitization may require specialized blood typing or prophylactic measures.

When to Seek Professional Help

Seek immediate medical attention if symptoms such as fever, chills, hypotension, or dark urine occur during or after a transfusion. Prompt evaluation is essential to prevent severe complications.

Tips for Medical Coders

Document the reaction’s acute nature, hemolytic component, and initial encounter status. Include details on transfusion history, antigen involvement, and clinical management. Ensure the code aligns with the specific documentation of non-ABO incompatibility and acute hemolysis.